4basebio Statistics
Total Valuation
4basebio has a market cap or net worth of GBP 185.68 million. The enterprise value is 192.83 million.
Market Cap | 185.68M |
Enterprise Value | 192.83M |
Important Dates
The next estimated earnings date is Friday, September 20, 2024.
Earnings Date | Sep 20, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
4basebio has 12.81 million shares outstanding. The number of shares has increased by 0.01% in one year.
Shares Outstanding | 12.81M |
Shares Change (YoY) | +0.01% |
Shares Change (QoQ) | +0.00% |
Owned by Insiders (%) | 14.73% |
Owned by Institutions (%) | 23.07% |
Float | 5.22M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 353.03 |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -25.16 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -27.36 |
Financial Position
The company has a current ratio of 2.21
Current Ratio | 2.21 |
Quick Ratio | 1.97 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | -1.48 |
Interest Coverage | -27.04 |
Financial Efficiency
Return on equity (ROE) is -231.29% and return on invested capital (ROIC) is -49.95%.
Return on Equity (ROE) | -231.29% |
Return on Assets (ROA) | -43.23% |
Return on Capital (ROIC) | -49.95% |
Revenue Per Employee | 6,024 |
Profits Per Employee | -91,250 |
Employee Count | 84 |
Asset Turnover | 0.04 |
Inventory Turnover | 0.71 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +127.64% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +127.64% |
50-Day Moving Average | 1,459.10 |
200-Day Moving Average | 1,087.16 |
Relative Strength Index (RSI) | 52.56 |
Average Volume (20 Days) | 1,099 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, 4basebio had revenue of GBP 506,000 and -7.67 million in losses. Loss per share was -0.62.
Revenue | 506,000 |
Gross Profit | 340,000 |
Operating Income | -8.17M |
Pretax Income | -8.35M |
Net Income | -7.67M |
EBITDA | -7.60M |
EBIT | -8.17M |
Loss Per Share | -0.62 |
Balance Sheet
The company has 3.31 million in cash and 10.46 million in debt, giving a net cash position of -7.15 million or -0.56 per share.
Cash & Cash Equivalents | 3.31M |
Total Debt | 10.46M |
Net Cash | -7.15M |
Net Cash Per Share | -0.56 |
Equity (Book Value) | -492,000 |
Book Value Per Share | -0.04 |
Working Capital | 2.75M |
Cash Flow
In the last 12 months, operating cash flow was -6.18 million and capital expenditures -871,000, giving a free cash flow of -7.05 million.
Operating Cash Flow | -6.18M |
Capital Expenditures | -871,000 |
Free Cash Flow | -7.05M |
FCF Per Share | -0.55 |
Margins
Gross Margin | 67.19% |
Operating Margin | -1,613.83% |
Pretax Margin | -1,650.99% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -1,393.08% |
Dividends & Yields
4basebio does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.01% |
Shareholder Yield | -0.01% |
Earnings Yield | -4.29% |
FCF Yield | -3.80% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |